Ascendis Pharma A/S Financial Assets
Ascendis Pharma A/S (ASND) had Financial Assets of EUR 776.96 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:FinancialAssets · last filed 2026-02-11
- 2025-12-31: Financial Assets 776.96M EUR.
- 2025-09-30: Financial Assets 680.80M EUR.
- 2025-06-30: Financial Assets 608.92M EUR.
- 2025-03-31: Financial Assets 589.11M EUR.
| Period end | Financial Assets |
|---|---|
| 2025-12-31 | 776.96M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 680.80M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 608.92M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 589.11M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 729.79M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 667.65M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 312.92M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 366.18M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 439.22M EUR 20-F · filed 2025-02-12 |
| 2023-03-31 | 610.33M EUR 6-K · filed 2023-04-27 |
| 2022-12-31 | 758.74M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 945.55M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 1.00B EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 1.08B EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 804.10M EUR 20-F · filed 2023-02-16 |